Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsResearchers evaluated outcomes in patients with hematological malignancy treated with myeloablative conditioning prior to haplo or umbilical cord blood hematopoietic stem cell transplantation.
[Blood Advances]
6445218 KDKENBYQ items 1 apa 0 default asc 1 166334 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-21719aee9fb113942987fe767bbcf19f%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22KDKENBYQ%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Wagner%20et%20al.%22%2C%22parsedDate%22%3A%222021-08-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EWagner%2C%20J.%20E.%2C%20Ballen%2C%20K.%20K.%2C%20Zhang%2C%20M.-J.%2C%20Allbee-Johnson%2C%20M.%2C%20Karanes%2C%20C.%2C%20Milano%2C%20F.%2C%20Verneris%2C%20M.%20R.%2C%20Eapen%2C%20M.%2C%20%26amp%3B%20Brunstein%2C%20C.%20G.%20%282021%29.%20Comparison%20of%20haploidentical%20and%20umbilical%20cord%20blood%20transplantation%20after%20myeloablative%20conditioning.%20%3Ci%3EBlood%20Advances%3C%5C%2Fi%3E%2C%20%3Ci%3Ebloodadvances.2021004462%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021004462%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021004462%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DKDKENBYQ%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Comparison%20of%20haploidentical%20and%20umbilical%20cord%20blood%20transplantation%20after%20myeloablative%20conditioning%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20E.%22%2C%22lastName%22%3A%22Wagner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Karen%20Kuhn%22%2C%22lastName%22%3A%22Ballen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mei-Jie%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mariam%22%2C%22lastName%22%3A%22Allbee-Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chatchada%22%2C%22lastName%22%3A%22Karanes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filippo%22%2C%22lastName%22%3A%22Milano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20R%22%2C%22lastName%22%3A%22Verneris%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary%22%2C%22lastName%22%3A%22Eapen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudio%20G%22%2C%22lastName%22%3A%22Brunstein%22%7D%5D%2C%22abstractNote%22%3A%22Haploidentical%20hematopoietic%20stem%20cell%20transplantation%20%28haplo%20HSCT%29%20has%20emerged%20as%20an%20important%20treatment%20modality.%20Most%20reports%20comparing%20haplo%20HSCT%20with%20post-transplant%20cyclophosphamide%20%28PTCy%29%20and%20other%20donor%20sources%20have%20focused%20on%20outcomes%20in%20older%20adults%20treated%20with%20reduced%20intensity%20conditioning.%20%20Therefore%2C%20in%20the%20current%20study%2C%20we%20evaluated%20outcomes%20in%20patients%20with%20hematological%20malignancy%20treated%20with%20myeloablative%20conditioning%20prior%20to%20haplo%20%28n%3D375%29%20or%20umbilical%20cord%20blood%20%28UCB%2C%20n%3D333%29%20HSCT.%20%20All%20haplo%20recipients%20received%20a%204%20of%208%20HLA%20matched%20graft%20while%20recipients%20of%20UCB%20were%20matched%20at%206-8%5C%2F8%20%28n%3D145%29%20or%20%5Cu22645%5C%2F8%20%28n%3D188%29%20HLA%20antigens.%20Recipients%20of%206-8%5C%2F8%20UCB%20transplants%20were%20younger%20%2814%20years%20vs.%2021%20and%2029%20years%29%20and%20more%20likely%20to%20have%20lower%20co-morbidity%20scores%20compared%20to%20recipients%20of%20%5Cu22645%5C%2F8%20UCB%20and%20haplo%20HSCT%20%2881%25%20vs.%2069%25%20and%2063%25%2C%20respectively%29.%20UCB%20recipients%20were%20more%20likely%20to%20have%20acute%20lymphoblastic%20leukemia%20and%20transplanted%20in%20second%20complete%20remission%20%28CR%29%20whereas%20haplo%20HSCT%20recipients%20were%20more%20likely%20to%20have%20acute%20myeloid%20leukemia%20in%20first%20CR.%20Other%20characteristics%2C%20including%20cytogenetic%20risk%20were%20similar.%20Survival%20at%203%20years%20was%20similar%20for%20the%20donor%20sources%20%2866%25%20haplo%20and%2061%25%20after%20%5Cu22645%5C%2F8%20and%2058%25%20after%206-8%5C%2F8%20UCB%29.%20%20Notably%2C%20relapse%20at%203%20years%20was%20lower%20in%20recipients%20of%20%5Cu22645%5C%2F8%20UCB%20%2821%25%2C%20p%3D0.03%29%20compared%20to%20haplo%20%2836%25%29%20and%206-8%5C%2F8%20UCB%20%2830%25%29.%20However%2C%20non-relapse%20mortality%20was%20higher%20in%20%5Cu22645%5C%2F8%20UCB%20%2821%25%29%20compared%20to%20other%20groups%20%28p%26lt%3B0.0001%29.%20These%20data%20suggest%20that%20haplo%20HSCT%20with%20PTCy%20after%20myeloablative%20conditioning%20provides%20an%20overall%20survival%20outcome%20comparable%20to%20that%20after%20UCB%20regardless%20HLA%20match%20group.%22%2C%22date%22%3A%22August%2030%2C%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1182%5C%2Fbloodadvances.2021004462%22%2C%22ISSN%22%3A%222473-9529%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1182%5C%2Fbloodadvances.2021004462%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-08-31T22%3A31%3A39Z%22%7D%7D%5D%7D
Wagner, J. E., Ballen, K. K., Zhang, M.-J., Allbee-Johnson, M., Karanes, C., Milano, F., Verneris, M. R., Eapen, M., & Brunstein, C. G. (2021). Comparison of haploidentical and umbilical cord blood transplantation after myeloablative conditioning. Blood Advances, bloodadvances.2021004462. https://doi.org/10.1182/bloodadvances.2021004462 Cite
